-
First Raypilot System Order in the U.S
Micropos Medical AB announced that the company has received an order through its U.S. subsidiary, Micropos Medical Inc., to deliver a Raypilot® system to the Medical University of South Carolina […]
-
Groundbreaking research shows single-dose radiotherapy has very low side effects despite high doses
New research published in Red Journal shows that single-dose radiotherapy, enhanced by motion control and the Raypilot System, can deliver high doses with very low side effects. The study demonstrates this approach significantly improves patients’ quality of life by minimizing toxicity.
-
Collaboration agreement with Johns Hopkins Medicine
Micropos Medical has today entered into a collaboration agreement with Johns Hopkins Medicine, JHM, in Baltimore, USA. The agreement means that JHM will evaluate the company’s product Raypilot® and conduct an in-depth study in Hypofractionation, so-called SBRT, for the treatment of prostate cancer together with the Micropos Raypilot System…
